Ironwood Pharma (IRWD) on Watch as Sale Potential Moves Higher - Analyst

February 9, 2021 9:59 AM EST
Get Alerts IRWD Hot Sheet
Price: $10.61 -2.12%

Rating Summary:
    8 Buy, 13 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 17 | Down: 13 | New: 41
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Gordon Haskett analyst Don Bilson said odds that Ironwood Pharma (NASDAQ: IRWD) will be sold "crept higher" after it was announced CEO Mark Mallon will be leaving the company next month.

Bilson said their guess would be the period between now and the naming of a new CEO serves as the most opportune time to sell the company.

Hedge fund Sarissa Capital is a 9% holder and its own Alex Denner picked up a board seat in November.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Hot Comments, Rumors